Russia’s Sputnik V Vaccine Appears Safe, Effective

Fake News on Sputnik V Covid1 Vaccine Proven Wrong

India's regulator has approved for emergency use the AstraZeneca vaccine and another developed at home by Bharat Biotech and the state-run Indian Council of Medical Research.

Until now, only Oxford/AstraZeneca's and China's CoronaVac have been given approval in the country.

With the shot at that point having only been tested by a few dozen volunteers, the proclamation was greeted with scepticism overseas.

The study follows a phase 3 trial in Moscow hospitals and clinics that included almost 22,000 participants age 18 and older.

The Russian Sputnik V vaccine is safe, it has 92 per cent efficacy against COVID, it can be used safely and is effective in seniors, Lpez-Gatell said.

The choice of name for the jab is highly symbolic.

Sputnik V has also now been approved for storage in normal fridges, as opposed to freezers, making transportation and distribution easier, Gamaleya scientists said on Tuesday.

The lyophilised (or freeze-dried) form of the vaccine can be stored at a temperature of +2 to +8 degrees Celsius, which allows for easy distribution worldwide, including hard-to-reach regions.

They include the former Soviet republics of Belarus, Armenia and Turkmenistan; Latin American nations including Argentina, Bolivia and Venezuela; African nations such as Algeria as well as Serbia, Iran, Palestine and United Arab Emirates.

Dr. Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India. The announcement of the new Russian Covid-19 vaccine created a so-called "Sputnik moment" for the global community.

Denouncing European delays, Viktor Orban's Hungary sidestepped the European Medicines Agency (EMA) and registered the vaccine on its own.

Mr Dmitriev mooted a partnership with other laboratories, while Merkel has proposed German aid for potential "joint production".

It remains unclear, however, if Sputnik V can stop the virus from spreading.

The quantities of doses that have been delivered overseas have mainly been symbolic, like the 20,000 exported to Bolivia. "We hope to roll out the product in March".

Brazil, India, Kazakhstan and South Korea are now producing the jab, though not all them have made it available to the public yet.

The European Commission said Monday (1 February) the shortfall in deliveries from Anglo-Swedish firm AstraZeneca had forced it to recalibrate its early coronavirus vaccination strategy.

Sputnik V now joins the club of proven and applied vaccines like those made by Pfizer, Moderna and Oxford/AstraZeneca.

The data published by Lancet was based on a study which was collected from almost 20,000 participants, three-quarters of whom received the two-dose regimen of the adenovirus-based vaccine, Gam-COVID-Vac, and one quarter received a placebo.

Related:

Comments


Other news